PMCC PMCC

Search tips
Search criteria

Advanced
Results 1-25 (68)
 

Clipboard (0)
None

Select a Filter Below

Journals
more »
Authors
Year of Publication
2.  Tumor Growth Mitigating Effects of Valproic Acid in Systemic Malignancies 
Journal of Thyroid Research  2015;2015:540183.
doi:10.1155/2015/540183
PMCID: PMC4531201  PMID: 26290769
3.  Emanuel syndrome: A rare disorder that is often confused with Kabuki syndrome 
doi:10.4103/1817-1745.159183
PMCID: PMC4489075  PMID: 26167235
4.  Synemin: an evolving role in tumor growth and progression 
doi:10.1007/s13539-013-0122-x
PMCID: PMC4248404  PMID: 24865380
5.  Proanthocyanidin and its emerging anti-neoplastic effects: recent insights 
Cytotechnology  2012;65(5):785-786.
doi:10.1007/s10616-012-9526-2
PMCID: PMC3967605  PMID: 23263889
6.  The anti-neoplastic effects of coumarin: an emerging concept 
Cytotechnology  2013;65(5):787-788.
The recent article by Liu et al. provided for highly interesting reading. Interestingly, recent data suggests that coumarin may exert significant anti-neoplastic effects in a number of systemic malignancies. Coumarin is also of clinical benefit in mammary malignancies. For instance, it attenuates the extent of extremity lymphedema following breast cancer surgery and radiation therapy. In one recent study, an almost 12.5 % decline in the volume of upper extremity lymphedema was noticed. As a result, quality of life is significantly improved. Similar attenuation of tumor growth has been seen in pulmonary malignancies. It mediates these anti-neoplastic effects by attenuating Bcl-2 expression within the tumor cells. On the other hand, Bax expression within the tumor cells is markedly accentuated. These changes have recently been confirmed in A549 cells.
doi:10.1007/s10616-013-9538-6
PMCID: PMC3967608  PMID: 23340967
Coumarin; Breast cancer; Prostate cancer
7.  Tenascin C and its modulatory role in tumor progression in systemic malignancies 
Cytotechnology  2013;65(5):789-790.
doi:10.1007/s10616-013-9552-8
PMCID: PMC3967620  PMID: 23475159
8.  Galangin and its emerging anti-neoplastic effects 
Cytotechnology  2012;65(4):467-468.
doi:10.1007/s10616-012-9507-5
PMCID: PMC3720963  PMID: 23095944
9.  Zoledronic Acid and Its Accentuating Effect on Tumor Radiosensitivity 
The Oncologist  2013;18(8):e21.
Recent data suggest that zoledronic acid may significantly augment the radiosensitivity of a number of systemic malignancies, including fibrosarcomas. Oncologists need to be aware of the radiosensitivity-enhancing properties of zoledronic acid.
doi:10.1634/theoncologist.2013-0054
PMCID: PMC3755938  PMID: 23986343
10.  Katayama syndrome in patients with schistosomiasis 
doi:10.1016/S2221-1691(14)60239-2
PMCID: PMC3868797  PMID: 25182445
12.  The emerging anti-proliferative role of Nutlin-3 in the pathogenesis of systemic malignancies 
Cancer Biology & Therapy  2013;14(1):5.
doi:10.4161/cbt.22629
PMCID: PMC3566052  PMID: 23114642
Nutlin 3; cancer; tumor
16.  The renoprotective effects of pentoxifylline: beyond its role in diabetic nephropathy 
doi:10.3904/kjim.2013.28.3.374
PMCID: PMC3654139  PMID: 23682235
Pentoxifylline; Renal insufficiency, chronic; Renal
20.  Tumor Growth Limiting Effects of Piceatannol 
BioMed Research International  2013;2013:514349.
doi:10.1155/2013/514349
PMCID: PMC3622287  PMID: 23586043
21.  Fenofibrate: direct attenuating effects on tumor growth 
Radiation Oncology Journal  2013;31(1):55.
doi:10.3857/roj.2013.31.1.55
PMCID: PMC3633232  PMID: 23620870
24.  Curcumin and its emerging intraocular benefits 
doi:10.1631/jzus.B1200273
PMCID: PMC3542964  PMID: 23303637

Results 1-25 (68)